New Rhein Healthcare Investors
Philadelphia, Pennsylvanianewrhein.com
Overview
New Rhein Healthcare Investors is a venture capital firm that applies a private equity business model to life sciences investing, focusing on assets with proven clinical safety and efficacy. The firm takes significant stakes in a small number of companies and actively manages their value creation. It invests in pharmaceutical, healthcare, and medical device companies with clinical-stage assets across the United States and Europe. New Rhein invests broadly across all therapeutic areas, including Alzheimer's, respiratory disease, urology, and migraine.
Portfolio Companies
7
Website
newrhein.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Butterfly Medical | May 2026 | Series C | Co-investor |
| Alveus Therapeutics | Feb 2026 | Series A Extension | Lead |
| Alveus Therapeutics | Jan 2026 | Series A | Lead |
| Corsair Pharma | Sep 2023 | Series B | Lead |
| American Injectables | Sep 2022 | Series A | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.